Clinical trial
Metabolic Effects of a Green Tea Extract in Multiple Sclerosis Patients
NCT01417312
Study timeline
Study start (unknown)2011-07-01Date precision: month
Registry last updated2021-07-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosis, Relapsing-Remittingunresolved
Interventions
Capsules with 160 mg Teavigo (at least 94% EGCG)DIETARY_SUPPLEMENT
PlaceboDIETARY_SUPPLEMENT
Sponsors & collaborators
Charite University, Berlin, Germanylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01417312 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.